Outsourced Pharma App Notes & Case Studies
-
Automated PUPSIT For Drug Product Applications
1/13/2026
Automated filtration systems streamline PUPSIT, leak testing, and integrity checks to ensure sterile drug product processing. Learn how these methods improve contamination control and compliance.
-
Developing A Large-Scale Tangential Flow Filtration Process
5/13/2024
Discover a process that can be modified to fit your downstream process and serves as a complete solution for concentration and diafiltration.
-
Analytical Method Saves Dual-API Injectable Project From Stalling
12/2/2025
Developing a stability-indicating analytical method for a dual-API injectable product requires careful forced degradation studies. Review the robust testing approach that ensured project progression.
-
Overcome Common Pre-Filled Syringe Challenges Through Partnership
5/23/2025
The pre-filled syringe space is one of the fastest growing pharma sectors, offering greater patient safety and lower manufacturing costs. But pre-filled doesn’t translate to easily filled; there are particular obstacles to overcome.
-
Microbial Recovery And Flow Performance With Membranes
2/25/2026
Compare membrane materials and pore sizes to assess their impact on flow rate and microbial recovery. See how fast filtration and ≥90% organism recovery offer guidance for selecting reliable membranes.
-
Cell Culture Media Filtration: Evaluating Cell Culture Performance
10/23/2025
Cell culture performance remained consistent across PES and PVDF filters, even under worst-case filtration conditions. Discover a practical framework for evaluating membrane impact on CHO cell growth.
-
Seizing Market Share Pre-Patent Expiry: The Evolution Of A CDMO Partnership In Navigating A Paragraph IV ANDA Submission
6/26/2024
The dynamic pharmaceutical landscape demands agility and strategic foresight. Explore how leveraging a key partnership helped to overcome a looming patent expiry for a second-generation acne medication.
-
Fab-Oligo Conjugation
8/25/2025
Explore a platform process towards the production of Fab-siRNA conjugates that proves to be scalable and efficient. Find out more about how bioconjugation services can improve your discovery program.
-
Accelerated LVV Manufacturing Enabled By Platform Excellence
11/25/2025
Discover how a manufacturing platform enabled the rapid production of lentiviral vector in eight months. Learn the strategy used to balance speed, risk mitigation, and the highest quality standards.
-
Tackling Antimicrobial Resistance
5/14/2024
Learn how three companies collaborated to develop a new antibiotic to address the increasing development of antimicrobial resistance (AMR) that threatens the global health landscape.